Delgado-Iribarren A, Wilhelmi I, Padilla B, Cañedo T, Gómez J, Elviro J
Servicio de Microbiología, Hospital Severo Ochoa, Leganés, Madrid.
Enferm Infecc Microbiol Clin. 1993 Jan;11(1):8-13.
The aim of the present article was to study the serology of intravenous drug user patients against the hepatitis B, C, D, and HIV, during 1990 and the follow-up during the same year, and 1991.
A study of 265 patients (mean age: 25 years, range: 16-45; 206 males and 59 females) was carried out. Forty-two percent came because of detoxication treatment, 30% requested diagnosis for hepatic disturbances and the only data provided in 28% were that they were intravenous drug users. None of the patients was an inmate from prisons.
Seroprevalences were 67.5% for the HBV, 75.6% for HCV, 17% for HDV and 50.2% for HIV. In the patients seronegative for HBV (65%) and HIV (58%) no new serologic controls were performed during the study period, while in those who underwent controls the rates of seroconversion were 43.3% and 32%, respectively. In 30% of all seroconversions to HBV coinfection with HDV was found and in 23% antibodies against HIV were observed.
Due to the high rates of infection obtained, the authors believe that serologic follow up of intravenous drug users is advisable.
本文旨在研究1990年静脉吸毒患者针对乙型、丙型、丁型肝炎及艾滋病毒的血清学情况,以及同年和1991年的随访情况。
对265例患者(平均年龄:25岁,范围:16 - 45岁;男性206例,女性59例)进行了研究。42%的患者因戒毒治疗前来,30%要求诊断肝脏疾病,28%仅提供了他们是静脉吸毒者这一信息。所有患者均非监狱服刑人员。
乙肝病毒(HBV)血清阳性率为67.5%,丙肝病毒(HCV)为75.6%,丁肝病毒(HDV)为17%,艾滋病毒(HIV)为50.2%。在乙肝病毒血清阴性(65%)和艾滋病毒血清阴性(58%)的患者中,研究期间未进行新的血清学检查,而在接受检查的患者中,血清转化率分别为43.3%和32%。在所有乙肝病毒血清转化患者中,30%发现合并丁肝病毒感染,23%检测到抗艾滋病毒抗体。
鉴于所获得的高感染率,作者认为对静脉吸毒者进行血清学随访是可取的。